International Research Journal of Pharmacy and Pharmacology

Giulia Escobar

King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Pharmaceutical Care Department, King Khal, Saudi Arabia

Publications

• Expert Review   
  Polypharmacy and Treatment Difficulties in Patients undergoing Chemotherapy
  Author(s): Giulia Escobar*
  
  Hemodialysis patients frequently experience polypharmacy. Medication-Related Problems (MRPs), expenditures, and increased hospital admissions are all linked to it. The prevalence of polypharmacy in our setting is poorly documented. The purpose of this study is to examine the predictors of polypharmacy and MRPs and their prevalence. In the outpatient hemodialysis unit, a cross-sectional study was carried out by us. Over the course of three months, a resident in pharmacy examined electronic prescribing records to identify MRPs and discussed therapeutic interventions to enhance effective therapeutic regimens. There were 83 patients included. The median age (interquartile range) was 63. IQR = 22), and the mean number of co-morbidities was 3.14 1.64. Half of the participants were male. The 95% confidence interval (CI) for polypharmacy was 96.7 percent (91.6%–99.7%). The highest MRPs .. View More»
  DOI: 10.14303/2251-0176.2023.63

  Abstract HTML PDF